A Respiratory Pharmacological Correlational Analytical Research Study on the Quantification of Drug Safety Levels and Patient Adherence to the Tertiary Treatment with Bronchodilator Drugs

β2 adrenergic receptor agonists, like salbutamol, formoterol, salmeterol and other β adrenergic agonists, are always the first-line treatment for the reduction of the bronchoconstriction associated with bronchial asthma and chronic obstructive pulmonary disease. The objective of this respiratory pharmacological correlational analytical research study was the quantification of drug safety levels and patient adherence to the tertiary treatment with bronchodilator drugs. This study has shown that the inhaled β2 adrenergic agonistic bronchodilators were very safe and well-tolerated treatment among the asthmatic patients, with sufficiently high patient treatment compliance and adherence.